| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 5 | 2021 | 235 | 2.01 | Why? |
| Rituximab | 6 | 2021 | 1096 | 1.43 | Why? |
| Nephrotic Syndrome | 3 | 2019 | 146 | 1.39 | Why? |
| Glomerulonephritis | 2 | 2020 | 226 | 1.27 | Why? |
| Kidney Diseases | 3 | 2021 | 1434 | 1.00 | Why? |
| Plasma Exchange | 2 | 2018 | 763 | 0.85 | Why? |
| Receptors, Phospholipase A2 | 1 | 2017 | 14 | 0.71 | Why? |
| Lupus Nephritis | 1 | 2019 | 113 | 0.70 | Why? |
| Erythema Nodosum | 1 | 2018 | 38 | 0.70 | Why? |
| Thrombospondins | 1 | 2017 | 26 | 0.70 | Why? |
| Immunologic Factors | 4 | 2021 | 4206 | 0.68 | Why? |
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2018 | 170 | 0.68 | Why? |
| Nephrosis, Lipoid | 1 | 2018 | 99 | 0.65 | Why? |
| Glomerulonephritis, Membranous | 1 | 2017 | 71 | 0.64 | Why? |
| Autoimmune Diseases | 3 | 2019 | 1996 | 0.63 | Why? |
| Contrast Media | 3 | 2018 | 1011 | 0.60 | Why? |
| Plasmapheresis | 1 | 2019 | 437 | 0.60 | Why? |
| Antibiotic Prophylaxis | 1 | 2018 | 399 | 0.58 | Why? |
| Biological Factors | 1 | 2017 | 276 | 0.54 | Why? |
| Arthritis | 1 | 2018 | 288 | 0.53 | Why? |
| Immune System Diseases | 1 | 2017 | 410 | 0.48 | Why? |
| Inflammasomes | 1 | 2019 | 710 | 0.48 | Why? |
| Lymphadenopathy | 1 | 2018 | 444 | 0.46 | Why? |
| Acute Kidney Injury | 3 | 2018 | 5762 | 0.39 | Why? |
| Antibodies, Antineutrophil Cytoplasmic | 3 | 2021 | 140 | 0.39 | Why? |
| Heart | 2 | 2018 | 1791 | 0.39 | Why? |
| Glomerulosclerosis, Focal Segmental | 2 | 2019 | 104 | 0.34 | Why? |
| Immunosuppressive Agents | 3 | 2021 | 6331 | 0.34 | Why? |
| Rheumatic Diseases | 2 | 2019 | 2675 | 0.31 | Why? |
| Kidney Transplantation | 3 | 2020 | 5397 | 0.29 | Why? |
| Search Engine | 2 | 2021 | 628 | 0.25 | Why? |
| Creatinine | 3 | 2018 | 1443 | 0.25 | Why? |
| Kidney Failure, Chronic | 1 | 2018 | 3222 | 0.24 | Why? |
| Remission Induction | 3 | 2021 | 950 | 0.22 | Why? |
| Neutrophils | 5 | 2017 | 5476 | 0.22 | Why? |
| Autoimmunity | 2 | 2019 | 841 | 0.22 | Why? |
| Sambucus | 1 | 2020 | 17 | 0.21 | Why? |
| Respiratory Tract Infections | 2 | 2018 | 6817 | 0.21 | Why? |
| Lymphocytosis | 1 | 2020 | 122 | 0.20 | Why? |
| Hypoventilation | 1 | 2018 | 17 | 0.19 | Why? |
| Renal Nutcracker Syndrome | 1 | 2017 | 3 | 0.18 | Why? |
| Hypothalamus | 1 | 2018 | 58 | 0.18 | Why? |
| Maintenance Chemotherapy | 1 | 2019 | 133 | 0.18 | Why? |
| Syndrome | 3 | 2018 | 1310 | 0.18 | Why? |
| Venous Thromboembolism | 1 | 2017 | 4273 | 0.18 | Why? |
| Renal Veins | 1 | 2017 | 13 | 0.18 | Why? |
| Antibodies, Monoclonal | 1 | 2017 | 8041 | 0.18 | Why? |
| Attention | 1 | 2021 | 335 | 0.18 | Why? |
| Maternal Age | 1 | 2019 | 244 | 0.18 | Why? |
| Induction Chemotherapy | 1 | 2019 | 149 | 0.18 | Why? |
| Ankle Joint | 1 | 2018 | 42 | 0.18 | Why? |
| Autonomic Nervous System Diseases | 1 | 2018 | 67 | 0.18 | Why? |
| Nasal Sprays | 1 | 2020 | 234 | 0.18 | Why? |
| Leukoencephalopathy, Progressive Multifocal | 1 | 2018 | 55 | 0.17 | Why? |
| Dyspnea | 3 | 2020 | 3847 | 0.17 | Why? |
| Inflammation | 2 | 2020 | 13255 | 0.17 | Why? |
| Dapsone | 1 | 2017 | 59 | 0.17 | Why? |
| Humans | 52 | 2021 | 930598 | 0.17 | Why? |
| Lupus Erythematosus, Systemic | 2 | 2018 | 1380 | 0.16 | Why? |
| Povidone-Iodine | 1 | 2020 | 213 | 0.16 | Why? |
| Mycophenolic Acid | 1 | 2019 | 383 | 0.16 | Why? |
| Neprilysin | 1 | 2017 | 112 | 0.16 | Why? |
| Skin Diseases, Vascular | 1 | 2017 | 69 | 0.16 | Why? |
| Receptors, Urokinase Plasminogen Activator | 1 | 2019 | 252 | 0.16 | Why? |
| Lymphocyte Depletion | 1 | 2018 | 293 | 0.16 | Why? |
| Plant Preparations | 1 | 2020 | 276 | 0.16 | Why? |
| Capillary Leak Syndrome | 1 | 2017 | 119 | 0.15 | Why? |
| Hematuria | 1 | 2017 | 284 | 0.15 | Why? |
| Adrenal Insufficiency | 1 | 2018 | 190 | 0.15 | Why? |
| Complement System Proteins | 1 | 2019 | 380 | 0.15 | Why? |
| Antigens | 1 | 2017 | 267 | 0.15 | Why? |
| Neuroendocrine Tumors | 1 | 2018 | 241 | 0.15 | Why? |
| Mouthwashes | 1 | 2020 | 432 | 0.15 | Why? |
| Prenatal Exposure Delayed Effects | 1 | 2019 | 319 | 0.14 | Why? |
| Mucous Membrane | 1 | 2017 | 305 | 0.14 | Why? |
| Genetic Association Studies | 1 | 2017 | 559 | 0.14 | Why? |
| Hyponatremia | 1 | 2018 | 371 | 0.14 | Why? |
| Observational Studies as Topic | 2 | 2019 | 1887 | 0.13 | Why? |
| Steroids | 1 | 2020 | 904 | 0.13 | Why? |
| Antidepressive Agents | 1 | 2019 | 509 | 0.13 | Why? |
| Polymorphism, Genetic | 2 | 2018 | 1074 | 0.13 | Why? |
| Morbidity | 1 | 2020 | 1426 | 0.13 | Why? |
| Coronavirus Infections | 9 | 2021 | 253789 | 0.13 | Why? |
| Treatment Failure | 1 | 2019 | 2106 | 0.12 | Why? |
| Microvessels | 1 | 2017 | 490 | 0.12 | Why? |
| Histocompatibility Antigens Class I | 1 | 2017 | 624 | 0.12 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.12 | Why? |
| Antiphospholipid Syndrome | 1 | 2018 | 533 | 0.12 | Why? |
| Risk Factors | 8 | 2021 | 71621 | 0.12 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.12 | Why? |
| Smoking Cessation | 1 | 2020 | 826 | 0.11 | Why? |
| Autism Spectrum Disorder | 1 | 2019 | 587 | 0.11 | Why? |
| Urinary Tract Infections | 1 | 2017 | 534 | 0.11 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2021 | 1261 | 0.11 | Why? |
| Multivariate Analysis | 2 | 2018 | 5440 | 0.10 | Why? |
| Coronary Vessels | 1 | 2017 | 914 | 0.10 | Why? |
| Precision Medicine | 1 | 2019 | 1477 | 0.09 | Why? |
| Delayed Diagnosis | 1 | 2019 | 1529 | 0.09 | Why? |
| Coronary Angiography | 1 | 2018 | 2275 | 0.09 | Why? |
| Tomography, X-Ray Computed | 3 | 2020 | 25144 | 0.09 | Why? |
| Extracellular Traps | 1 | 2017 | 1036 | 0.09 | Why? |
| Lymphopenia | 1 | 2020 | 2669 | 0.09 | Why? |
| Pregnancy Complications | 1 | 2019 | 1388 | 0.09 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1573 | 0.09 | Why? |
| Adaptive Immunity | 1 | 2019 | 2585 | 0.08 | Why? |
| Hematologic Neoplasms | 1 | 2020 | 2105 | 0.08 | Why? |
| Kidney | 2 | 2018 | 3648 | 0.08 | Why? |
| Thrombocytopenia | 1 | 2020 | 2093 | 0.08 | Why? |
| Methylprednisolone | 1 | 2018 | 2107 | 0.08 | Why? |
| C-Reactive Protein | 3 | 2020 | 7972 | 0.08 | Why? |
| Genetic Predisposition to Disease | 2 | 2018 | 4027 | 0.08 | Why? |
| Autoantibodies | 1 | 2017 | 2094 | 0.08 | Why? |
| Eye Diseases | 1 | 2017 | 1150 | 0.08 | Why? |
| Glucocorticoids | 2 | 2019 | 4431 | 0.07 | Why? |
| Pandemics | 12 | 2021 | 389249 | 0.07 | Why? |
| Myocardium | 1 | 2017 | 2323 | 0.07 | Why? |
| Percutaneous Coronary Intervention | 2 | 2018 | 3646 | 0.07 | Why? |
| Anti-Inflammatory Agents | 2 | 2021 | 6153 | 0.07 | Why? |
| Clinical Trials as Topic | 2 | 2021 | 7330 | 0.07 | Why? |
| Fever | 2 | 2020 | 7795 | 0.07 | Why? |
| Renal Dialysis | 1 | 2021 | 4358 | 0.07 | Why? |
| Disease Models, Animal | 2 | 2021 | 10998 | 0.06 | Why? |
| Animals | 7 | 2021 | 78931 | 0.06 | Why? |
| Biomarkers | 4 | 2019 | 23361 | 0.06 | Why? |
| Gastrointestinal Diseases | 1 | 2017 | 2580 | 0.06 | Why? |
| Internet | 1 | 2020 | 6204 | 0.06 | Why? |
| Venous Thrombosis | 1 | 2017 | 2739 | 0.06 | Why? |
| Inflammatory Bowel Diseases | 1 | 2019 | 3209 | 0.06 | Why? |
| Multiple Sclerosis | 1 | 2017 | 2600 | 0.06 | Why? |
| Lung | 2 | 2020 | 31049 | 0.05 | Why? |
| Immunocompromised Host | 1 | 2018 | 5150 | 0.05 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.05 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.05 | Why? |
| Immunity, Innate | 1 | 2019 | 6570 | 0.05 | Why? |
| Female | 12 | 2020 | 380317 | 0.05 | Why? |
| Chills | 1 | 2020 | 102 | 0.05 | Why? |
| ST Elevation Myocardial Infarction | 1 | 2017 | 3051 | 0.05 | Why? |
| Area Under Curve | 2 | 2018 | 2564 | 0.05 | Why? |
| Middle Aged | 8 | 2020 | 270681 | 0.05 | Why? |
| STAT Transcription Factors | 1 | 2021 | 173 | 0.05 | Why? |
| Social Media | 1 | 2021 | 5798 | 0.05 | Why? |
| Valine | 1 | 2021 | 359 | 0.05 | Why? |
| DNA Copy Number Variations | 1 | 2018 | 84 | 0.05 | Why? |
| Leukocytosis | 1 | 2020 | 280 | 0.05 | Why? |
| JC Virus | 1 | 2018 | 39 | 0.04 | Why? |
| Physicians | 1 | 2018 | 4214 | 0.04 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.04 | Why? |
| Male | 11 | 2020 | 367725 | 0.04 | Why? |
| Succimer | 1 | 2017 | 4 | 0.04 | Why? |
| Republic of Korea | 2 | 2021 | 5858 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.04 | Why? |
| Chemotaxis | 1 | 2017 | 67 | 0.04 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.04 | Why? |
| Reflex | 1 | 2017 | 22 | 0.04 | Why? |
| Podocytes | 1 | 2018 | 82 | 0.04 | Why? |
| Free Radicals | 1 | 2017 | 55 | 0.04 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.04 | Why? |
| Exome | 1 | 2018 | 207 | 0.04 | Why? |
| Cyclophosphamide | 1 | 2019 | 387 | 0.04 | Why? |
| Janus Kinases | 1 | 2021 | 414 | 0.04 | Why? |
| Lymphoma, Non-Hodgkin | 1 | 2020 | 403 | 0.04 | Why? |
| Carbamates | 1 | 2021 | 485 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2021 | 12361 | 0.04 | Why? |
| Constriction, Pathologic | 1 | 2017 | 212 | 0.04 | Why? |
| Epidemiologic Methods | 1 | 2020 | 392 | 0.04 | Why? |
| Age of Onset | 1 | 2018 | 557 | 0.04 | Why? |
| Pharmacovigilance | 1 | 2021 | 501 | 0.04 | Why? |
| Pyrrolidines | 1 | 2021 | 558 | 0.04 | Why? |
| Kidney Glomerulus | 1 | 2018 | 144 | 0.04 | Why? |
| Peroxidase | 1 | 2017 | 207 | 0.04 | Why? |
| Lymphoma, B-Cell | 1 | 2018 | 166 | 0.04 | Why? |
| Adolescent | 4 | 2020 | 86841 | 0.04 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Adverse Drug Reaction Reporting Systems | 1 | 2021 | 694 | 0.04 | Why? |
| Sofosbuvir | 1 | 2021 | 518 | 0.04 | Why? |
| Gadolinium | 1 | 2017 | 318 | 0.04 | Why? |
| Aged | 5 | 2020 | 215776 | 0.04 | Why? |
| Human Umbilical Vein Endothelial Cells | 1 | 2017 | 286 | 0.04 | Why? |
| DNA Mutational Analysis | 1 | 2018 | 581 | 0.04 | Why? |
| Databases, Factual | 2 | 2021 | 6248 | 0.04 | Why? |
| Time Factors | 1 | 2019 | 31397 | 0.04 | Why? |
| Child, Preschool | 4 | 2020 | 36283 | 0.04 | Why? |
| Causality | 1 | 2019 | 857 | 0.04 | Why? |
| Imidazoles | 1 | 2021 | 631 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Purines | 1 | 2021 | 816 | 0.04 | Why? |
| Blood Sedimentation | 1 | 2017 | 508 | 0.04 | Why? |
| Azetidines | 1 | 2021 | 722 | 0.03 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.03 | Why? |
| Hypertrophy, Left Ventricular | 1 | 2017 | 219 | 0.03 | Why? |
| Aged, 80 and over | 3 | 2020 | 88759 | 0.03 | Why? |
| Platelet Count | 1 | 2020 | 1381 | 0.03 | Why? |
| Prognosis | 4 | 2018 | 32490 | 0.03 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.03 | Why? |
| Adenosine Monophosphate | 2 | 2021 | 5652 | 0.03 | Why? |
| Alanine | 2 | 2021 | 5687 | 0.03 | Why? |
| Age Factors | 3 | 2020 | 21039 | 0.03 | Why? |
| Immunoglobulin G | 1 | 2017 | 21571 | 0.03 | Why? |
| Child | 5 | 2020 | 70012 | 0.03 | Why? |
| Signal Transduction | 2 | 2021 | 7207 | 0.03 | Why? |
| Environment | 1 | 2019 | 769 | 0.03 | Why? |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2020 | 877 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2018 | 11497 | 0.03 | Why? |
| Complement Activation | 1 | 2019 | 949 | 0.03 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 1 | 2021 | 1165 | 0.03 | Why? |
| Gene Regulatory Networks | 1 | 2017 | 820 | 0.03 | Why? |
| Hydrogen Peroxide | 1 | 2017 | 680 | 0.03 | Why? |
| Vitamins | 1 | 2021 | 1208 | 0.03 | Why? |
| Sulfonamides | 1 | 2021 | 1294 | 0.03 | Why? |
| Meta-Analysis as Topic | 1 | 2018 | 1289 | 0.03 | Why? |
| Interleukin-8 | 1 | 2017 | 964 | 0.03 | Why? |
| Probiotics | 1 | 2019 | 694 | 0.03 | Why? |
| Multiple Myeloma | 1 | 2020 | 1064 | 0.03 | Why? |
| Drug Combinations | 1 | 2021 | 3852 | 0.03 | Why? |
| Genome-Wide Association Study | 1 | 2018 | 1648 | 0.03 | Why? |
| Vasculitis | 1 | 2017 | 691 | 0.03 | Why? |
| Leukocyte Count | 1 | 2020 | 3178 | 0.03 | Why? |
| Leukocytes | 1 | 2017 | 1046 | 0.03 | Why? |
| Pyrazoles | 1 | 2021 | 1791 | 0.03 | Why? |
| Crohn Disease | 1 | 2019 | 959 | 0.02 | Why? |
| Colitis, Ulcerative | 1 | 2019 | 1037 | 0.02 | Why? |
| Drug Evaluation, Preclinical | 1 | 2021 | 3347 | 0.02 | Why? |
| Recurrence | 1 | 2019 | 3675 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2019 | 2483 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.02 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.02 | Why? |
| Genomics | 1 | 2020 | 3118 | 0.02 | Why? |
| World Health Organization | 1 | 2021 | 4213 | 0.02 | Why? |
| Bayes Theorem | 1 | 2017 | 3237 | 0.02 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.02 | Why? |
| Stroke Volume | 1 | 2017 | 2153 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2021 | 7268 | 0.02 | Why? |
| Adult | 3 | 2020 | 244371 | 0.02 | Why? |
| Cough | 1 | 2020 | 4891 | 0.02 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2017 | 3567 | 0.02 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.02 | Why? |
| Public Health | 2 | 2021 | 16359 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2018 | 3129 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2018 | 3607 | 0.02 | Why? |
| Infant | 2 | 2018 | 30274 | 0.02 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.02 | Why? |
| Oxygen | 1 | 2017 | 3715 | 0.02 | Why? |
| China | 2 | 2021 | 50654 | 0.02 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2020 | 53120 | 0.01 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
| Phylogeny | 1 | 2020 | 13341 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2021 | 10649 | 0.01 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.01 | Why? |
| Adrenal Cortex Hormones | 1 | 2017 | 6537 | 0.01 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.01 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.01 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.01 | Why? |
| Mice | 1 | 2018 | 21357 | 0.01 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.01 | Why? |
| Pregnancy | 1 | 2019 | 23879 | 0.01 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.01 | Why? |
| Italy | 1 | 2021 | 38444 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
| Retrospective Studies | 2 | 2018 | 105322 | 0.01 | Why? |
| United States | 1 | 2021 | 46150 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Hospitalization | 1 | 2018 | 54280 | 0.01 | Why? |